Last reviewed · How we verify
NCT03627117: CoIL-Basel
Influence of CBD on Episodic Memory in Healthy Subjects
NA trial testing Verum in Healthy in 39 participants. Completed in 8 December 2018.
8 December 2018
Quick facts
| Lead sponsor | Prof. Dominique de Quervain, MD |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 39 |
| Start date | 13 August 2018 |
| Primary completion | 8 December 2018 |
| Estimated completion | 8 December 2018 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Verum — full drug profile →
- Placebo
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Prof. Dominique de Quervain, MD
Who can join
Adults 18 to 30, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Placebo controlled, randomized, double blind, cross-over design. Single vape of 0.25ml 5% CBD e-liquid (12.5mg CBD) and single vape of 0.25ml e-liquid, tastes like lemon and madeleine. 15min vape time each. A total of 34 participants, equal number of male and female. There will be replacement of Drop-Outs until data from 34 participants are completed. The primary endpoint will be performance in a verbal memory task. The secondary endpoint will be performance in a working memory test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03627117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Verum
Trials testing the same drug.
- NCT07017244 — Effect of a Dietary Supplement vs Low-dosage Product on Infant Gastrointestinal Discomfort and Colics · NA · not yet recruiting
- NCT06123234 — Randomised Double-blind Active vs. Placebo Clinical Trial on the Effect of a Food Supplement on IBS in Children · NA · unknown
- NCT05598749 — Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study · NA · completed
- NCT06218225 — Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections · NA · completed
- NCT05472285 — Evaluation of the Effects of a Food Supplementation on the Improvement of Cognitive Functions in Healthy Seniors · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Prof. Dominique de Quervain, MD trials
Trials by the same sponsor.
- NCT04516603 — Influence of Fampridine on Working Memory in Healthy Subjects · Phase 2 · withdrawn
- NCT07191288 — Assessing the Acute Effects of Virtual Reality Interventions on Stress · NA · not yet recruiting
- NCT07191275 — Study on the Effect of Transcranial Magnetic Stimulation on the Perception of Emotional Images · NA · recruiting
- NCT06047899 — Influence of Luteolin for Two Weeks on Memory in Healthy Subjects · NA · completed
- NCT05847933 — Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03627117 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prof. Dominique de Quervain, MD
- Last refreshed: 25 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03627117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing